The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(4-((2-(3-Bromophenyl)-4,5-diphenyl-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)-N-(2-ethoxyphenyl)acetamide ID: ALA3891396
PubChem CID: 134137273
Max Phase: Preclinical
Molecular Formula: C34H29BrN6O2
Molecular Weight: 633.55
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCOc1ccccc1NC(=O)Cn1cc(Cn2c(-c3cccc(Br)c3)nc(-c3ccccc3)c2-c2ccccc2)nn1
Standard InChI: InChI=1S/C34H29BrN6O2/c1-2-43-30-19-10-9-18-29(30)36-31(42)23-40-21-28(38-39-40)22-41-33(25-14-7-4-8-15-25)32(24-12-5-3-6-13-24)37-34(41)26-16-11-17-27(35)20-26/h3-21H,2,22-23H2,1H3,(H,36,42)
Standard InChI Key: FJCHCNBXHBLYIR-UHFFFAOYSA-N
Molfile:
RDKit 2D
43 48 0 0 0 0 0 0 0 0999 V2000
7.3760 -8.5408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1966 -8.4691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9004 -7.8666 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.0270 -9.2907 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2022 -9.3624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8545 -10.1126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0315 -10.1816 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5566 -9.5017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9074 -8.7572 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7324 -8.6870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5457 -7.7233 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.1231 -6.9865 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.6834 -6.3890 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.4297 -6.7328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3308 -7.5516 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1523 -6.3347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8449 -5.0349 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6017 -4.2467 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.7629 -4.2423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5088 -5.0136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1697 -5.5096 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.7195 -5.2616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1140 -4.7047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3253 -4.9399 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1416 -5.7461 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7489 -6.3058 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5358 -6.0637 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2872 -3.5681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6213 -2.8290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1486 -2.1526 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3233 -2.2232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9749 -2.9729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4481 -3.6520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6232 -5.3040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7747 -6.1126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5521 -6.3818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1751 -5.8421 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0157 -5.0299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2384 -4.7645 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7081 -7.1922 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
6.0831 -7.9403 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.6706 -7.2258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0831 -6.5113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 2 0
1 4 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
5 10 2 0
4 5 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
11 15 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
17 21 1 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
22 27 2 0
20 22 1 0
28 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 33 1 0
28 33 2 0
19 28 1 0
17 34 1 0
16 21 1 0
14 16 1 0
2 11 1 0
34 35 2 0
35 36 1 0
36 37 2 0
37 38 1 0
38 39 2 0
39 34 1 0
36 40 1 0
10 41 1 0
41 42 1 0
42 43 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 633.55Molecular Weight (Monoisotopic): 632.1535AlogP: 7.32#Rotatable Bonds: 10Polar Surface Area: 86.86Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: 11.85CX Basic pKa: 4.43CX LogP: 7.44CX LogD: 7.44Aromatic Rings: 6Heavy Atoms: 43QED Weighted: 0.17Np Likeness Score: -1.70
References 1. Wang G, Peng Z, Wang J, Li J, Li X.. (2016) Synthesis and biological evaluation of novel 2,4,5-triarylimidazole-1,2,3-triazole derivatives via click chemistry as α-glucosidase inhibitors., 26 (23): [PMID:27810241 ] [10.1016/j.bmcl.2016.10.057 ] 2. Dhameja M, Gupta P.. (2019) Synthetic heterocyclic candidates as promising α-glucosidase inhibitors: An overview., 176 [PMID:31112894 ] [10.1016/j.ejmech.2019.04.025 ]